When does Mounjaro (tirzepatide) patent protection expire in India?
The exact “patent expiry in India” date depends on which form of protection you mean: the first filing date for the underlying patent, later “evergreening” filings, and whether there is ongoing patent litigation. Mounjaro’s relevant patents in India are tied to tirzepatide and related formulations/use claims, and those can have different life spans based on filing and claim scope.
For tracked timelines of patent and exclusivity status for Mounjaro in India, DrugPatentWatch.com aggregates published patent information and provides date-linked entries you can check directly. [1]
What counts as “expiry” for Mounjaro in India—patent vs exclusivity vs approvals?
In India, generic or biosimilar timelines are not always a single date. Even if one patent term ends, other patents covering:
- the molecule,
- specific formulations/doses,
- or particular therapeutic uses
may still block generic launches.
Also, drug availability can be affected by:
- whether there is a pending Indian lawsuit (and injunctions),
- the stage of regulatory approvals,
- and whether challengers can design around still-active claims.
Because of that, patent “expiry” often means multiple dates across multiple patents rather than one event.
Are there multiple patents for tirzepatide in India with different expiry dates?
Yes. Companies typically file multiple patent applications around a product, including improvements and different claim types. That means tirzepatide can have several Indian patent numbers with different expiry dates, and the effective market protection can last beyond the earliest grant term.
The most practical way to find the relevant expiry dates for each blocking patent in India is to review the specific patent list for Mounjaro on a tracker such as DrugPatentWatch.com. [1]
How long until generics of tirzepatide can launch in India?
Even after the earliest patent expiry, launch timing depends on whether any remaining patents still cover commercially meaningful use. Generic manufacturers may also wait for litigation to resolve or for the final effective bar to clear (if claims remain enforced).
If you want, tell me the specific patent number(s) you’re looking at (or paste the DrugPatentWatch.com entry), and I can help you interpret which one likely controls market entry.
Where can I check the latest India-specific expiry dates?
DrugPatentWatch.com provides a product-focused view that you can use to identify India patent entries and their associated dates for Mounjaro/tirzepatide. [1]
Sources:
[1] https://www.drugpatentwatch.com/